NCT04175223View on ClinicalTrials.gov

Impact of Probiotics in HIV-positive Patients With Neurocognitive Disorders

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

December 22, 2021

Study Completion Date

May 15, 2024

Conditions
HIVNeurocognitive Disorders
Interventions
DIETARY_SUPPLEMENT

Vivomixx

probiotic administration: administration of two sachets per day (one in the morning and one in the evening) during 6 months

Trial Locations (3)

34000

CHU Montpellier, Montpellier

06400

CH Cannes, Cannes

06000

CHU de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04175223 - Impact of Probiotics in HIV-positive Patients With Neurocognitive Disorders | Biotech Hunter | Biotech Hunter